Nancy Lurker Discusses Bringing Her Commercial Experience, Insights to Drug Delivery Upstart pSivida
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 126″]
Newly appointed President and CEO Nancy Lurker explains why she took over as CEO and President at pSivida and gives details on the company’s early clinical testing results in the recurrence of uveitis. Lurker hits upon filing for regulatory approval filings, building a sale team and operating a drug company at a time of political uncertainty.
Nancy brings deep industry knowledge and is passionate about bridging the rapids from clinical R&D to life saving, and enhancing treatments for patients.